| Literature DB >> 35976335 |
Ana Júlia Reis1, Juliana Lemos Dal Pizzol1, Rúbia Gattelli2, Andrea von Groll1, Daniela Fernandes Ramos1, Ivy Bastos Ramis1, Afrânio Kritski3, José Roberto Lapa E Silva3, Pedro Eduardo Almeida da Silva1.
Abstract
BACKGROUND: Tuberculosis (TB) remains a serious public health problem, with approximately 10 million new cases reported annually. Knowledge about the quantitative evolution of theses and dissertations (T&Ds) examining human TB in Brazil can contribute to generating strategic planning for training professionals in this field and disease control. Therefore, this study highlights the role of T&Ds on TB in national scientific disclosures.Entities:
Mesh:
Year: 2022 PMID: 35976335 PMCID: PMC9405934 DOI: 10.1590/0037-8682-0198-2022
Source DB: PubMed Journal: Rev Soc Bras Med Trop ISSN: 0037-8682 Impact factor: 2.141
Distribution of general theses and dissertations and those related to tuberculosis per year.
| Academic dissertations | Professional dissertations | Theses | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General* | TB | General | TB | General | TB | |||||||
| n | % | n | % | N | % | n | % | n | % | N | % | |
| 2013 | 45,822 | 67.8 | 115 | 64.6 | 6,059 | 9.0 | 13 | 7.3 | 15,653 | 23.2 | 50 | 28.1 |
| 2014 | 46,370 | 65.6 | 127 | 65.1 | 7,012 | 9.9 | 15 | 7.7 | 17,286 | 24.5 | 53 | 27.2 |
| 2015 | 47,801 | 63.0 | 121 | 61.1 | 9,086 | 12.0 | 15 | 7.6 | 18,996 | 25.0 | 62 | 31.3 |
| 2016 | 49,055 | 61.1 | 95 | 48.0 | 10,618 | 13.2 | 41 | 20.7 | 20,605 | 25.7 | 62 | 31.3 |
| 2017 | 50,636 | 60.8 | 115 | 59.0 | 11,036 | 13.2 | 15 | 7.7 | 21,609 | 25.9 | 65 | 33.3 |
| 2018 | 52,068 | 59.1 | 103 | 52.3 | 13,125 | 14.9 | 23 | 11.7 | 22,927 | 26.0 | 71 | 36.0 |
| 2019 | 53,760 | 57.4 | 94 | 51.9 | 15,635 | 16.7 | 23 | 12.7 | 24,297 | 25.9 | 64 | 35.4 |
*Total production and percentage of each production type per year in Brazil. **Total productions and percentage of each type of production per year, associated with TB.
Distribution of theses and dissertations on tuberculosis according to the CAPES knowledge areas and their corresponding assessment areas.
| Knowledge area | N | % | Assessment areas |
|---|---|---|---|
| Medicine | 162 | 12.1 | Medicine I |
| Medicine | 209 | 15.6 | Medicine II |
| Medicine | 2 | 0.15 | Medicine III |
| Collective health | 224 | 16.7 | Collective health |
| Nursing | 181 | 13.5 | Nursing |
| Pharmacy | 126 | 9.4 | Pharmacy |
| Chemistry | 83 | 6.2 | Chemistry |
| General biology | 60 | 4.5 | Biological sciences I |
| Interdisciplinary | 60 | 4.5 | Interdisciplinary |
| Immunology | 33 | 2.5 | Biological sciences III |
| Biotechnology | 26 | 1.9 | Biotechnology |
| Microbiology | 18 | 1.3 | Biological sciences III |
| Biochemistry | 17 | 1.3 | Biological sciences II |
| Genetics | 16 | 1.2 | Biological sciences I |
| Education | 13 | 1.0 | Education |
| Parasitology | 10 | 0.7 | Biological sciences III |
| Environmental sciences | 9 | 0.7 | Environmental sciences |
| Electrical engineering | 9 | 0.7 | Engineering IV |
| Pharmacology | 8 | 0.6 | Biological sciences II |
| Others* | 76 | 5.5 | Others** |
|
|
|
|
*administration (0.1% - 02/1,342); agronomy (0.4% - 06/1,342); botany (0.1% - 01/1,342); computer science (0.2% - 03/1,342); information science (0.1% - 02/1,342); food science and technology (0.1% - 01/1,342); political science (0.1% - 01/1,342); communication (0.1% - 01/1,342); ecology (0.1% - 01/1,342); economy (0.4% - 05/1,342); education (0.1% - 01/1,342); biomedical engineering (0.1% - 01/1,342); materials and metallurgical engineering (0.1% - 02/1,342); production engineering (0.1% - 02/1,342); mechanical engineering (0.1% - 01/1,342); nuclear engineering (0.1% - 01/1,342); chemical engineering (0.1% - 01/1,342); physics (0.3% - 04/1,342); geography (0.4% - 05/1,342); history (0.4% - 06/1,342); language (0.2% - 03/1,342); linguistics (0.1% - 01/1,342); mathematics (0.1% - 01/1,342); materials (0.4% - 05/1,342); veterinary medicine (0.4% - 05/1,342); morphology (0.1% - 01/1,342); nutrition (0.1% - 01/1,342); odontology (0.4% - 06/1,342); urban and regional planning (0.1% - 02/1,342); social service (0.1% - 01/1,342); sociology (0.1% - 02/1,342); zootechnics (0.1% - 01/1,342). **public and business administration, accounting science and tourism (0.1% - 02/1,342); astronomy/physics (0.3% - 04/1,342); biodiversity (0.1% - 02/1,342); computer science (0.2% - 03/1,342); food science (0.1% - 01/1,342); political science and international relations (0.1% - 01/1,342); agrarian sciences I (0,4% - 06/1342); biological sciences II (0.1% - 01/1,342); communication and information (0.2% - 03/1,342); economy (0.4% - 05/1,342); education (0.1% - 01/1,342); engineering II (0.3% - 04/1,342); engineering III (0.2% - 03/1,342); engineering IV (0.1% - 01/1,342,); geography (0.4% - 05/1,342); history (0.4% - 06/1,342); language/linguistics (0.1% - 01/1,342); linguistics and literature (0.2% - 03/1,342); mathematics/probability and statistics (0.1% - 01/1,342); materials (0.4% - 05/1,342); veterinary medicine (0.4% - 05/1,342); nutrition (0.1% - 01/1,342); odontology (0.4% - 06/1,342); urban and regional planning/demography (0.1% - 02/1,342); social service (0.1% - 01/1,342); sociology (0.1% - 02/1,342); zootechnics/fishing resources (0.1% - 01/1,342).
FIGURE 1:Intersections between the number of theses and dissertations with the main and associated themes. *Illustration made using Microsoft PowerPoint to visually demonstrate the relationship between themes.
Number of theses and dissertations related to different groups of patients at risk for tuberculosis development and the prevalence of the disease among these groups in Brazil.
| Risk groups | % | N | % in Brazil& |
|---|---|---|---|
| TB/HIV coinfection | 8.2 | 110 | 11.0 |
| Prisoners | 2.9 | 39 | 8.9 |
| Children and teenagers | 2.5 | 34 | 8.4# |
| Indigenous individuals | 1.6 | 21 | 1.0 |
| Health professionals | 1.5 | 20 | 1.0 |
| Diabetes mellitus | 1.3 | 18 | 7.2 |
| Elderly people | 1.2 | 16 | 14.1* |
| Homeless populations | 0.8 | 11 | 3.0 |
| Alcohol, drugs and/or tobacco users | 0.8 | 11 | 3.9 |
Source: National Congress, Federal Government. BRASIL, 1990: According to the Child and Teenagers Statute, were considered children those aged up to 12 years and teenagers those aged up to 18 years. Source: National Congress, Federal Government. BRASIL, 2003: According to the Elderly Statute, all patients aged > 60 years were considered. &Source: SINAN, 2021. Calculation based on the average per year of all TB cases in Brazil between 2013 and 2019 (89,104): # children and teenagers (< 1 year, 1-4, 5-9, 10-14, and 15-19 years); * and older adults (60-64, 65-69, 70-79, and ≥ 80 years).
FIGURE 2:Distribution of higher education institutions, theses, and dissertations on tuberculosis in different regions of Brazil, according to the institution academic-administrative classification (federal, state, and private).
Health sciences descriptors.
| Term | Descriptor in Portuguese | Synonyms | Related terms | Generic terms |
|---|---|---|---|---|
| Tuberculosis | Tuberculosis |
| Antituberculous Interferon-gamma release tests |
|
| Sanitary pulmonology TB | Tuberculin test | Communicable diseases | ||
|
|
|
| Antituberculous |
|
|
| H37Rv | |||
|
|
| Mycobacteria |
| |
| Antituberculostatics | Antitubercular Agents | Agent, Anti-Tuberculosis | Tuberculostatics | Antibacterials |
| Multiple drug resistant tuberculosis | ||||
| Agent, Antitubercular | ||||
| Agent, Tuberculostatic | ||||
| Agents, Antitubercular | ||||
| Agents, Tuberculostatic | ||||
| Antitubercular Drug | ||||
| Anti Tuberculosis Drugs | ||||
| Anti Tuberculosis Drug | ||||
| Antitubercular Drug | ||||
| Antitubercular Drugs | ||||
| Drug, Anti-Tuberculosis | ||||
| Drug, Antitubercular | ||||
| Drugs, Anti-Tuberculosis | ||||
| Drugs, Antitubercular | ||||
| Tuberculostatic Agent | ||||
| Tuberculostatic Agents | ||||
| Isoniazid | Isoniazid | Isonicotinic acid hydrazide | Hydrazines | |
| Isonicotinic acids | ||||
| Rifampicin | Rifampicin | Rifampicin | Rifamycins |
Main and associated themes
| Main theme* | Associated theme* | Total | ||
|---|---|---|---|---|
| N | N | N | % | |
| Attention/health care | 253 | 205 | 458 | 33.9 |
| Epidemiology | 271 | 138 | 409 | 30.5 |
| Treatment | 165 | 193 | 358 | 26.7 |
| Diagnosis | 160 | 101 | 261 | 19.4 |
| Drugs | 198 | 15 | 213 | 15.8 |
| Genetics | 57 | 90 | 147 | 10.9 |
| Immunology | 106 | 16 | 122 | 91 |
| Resistance | 74 | 41 | 115 | 8.6 |
| Biochemistry | 36 | 40 | 76 | 5.7 |
| Others** | 122 | |||
*Based on total T&D. **T&D not classified in any of the themes.
Theses and dissertations geographical and institutional characterization
| Federated Unit | Theses and dissertations | % | Prevalence by 100,000 inhabitants | Higher education institutions | Postgraduate Programs |
|---|---|---|---|---|---|
| Southeast | |||||
| Rio de Janeiro | 303 | 22.6 | 79.5 | 11 | 67 |
| São Paulo | 243 | 18.1 | 45.0 | 20 | 81 |
| Minas Gerais | 103 | 7.7 | 19.4 | 14 | 40 |
| Espírito Santo | 34 | 2.5 | 33.5 | 1 | 5 |
| Total | 683 | 50.9 | 45.1 | 46 | 193 |
| Northeast | |||||
| Pernambuco | 58 | 4.3 | 59.2 | 6 | 17 |
| Bahia | 42 | 3.1 | 36.9 | 4 | 14 |
| Paraíba | 37 | 2.8 | 33.6 | 4 | 8 |
| Ceará | 39 | 2.9 | 45.4 | 4 | 14 |
| Rio Grande do Norte | 21 | 1.6 | 36.9 | 1 | 7 |
| Maranhão | 18 | 1.3 | 33.6 | 3 | 8 |
| Piauí | 4 | 0.3 | 25.3 | 2 | 2 |
| Sergipe | 4 | 0.3 | 36.1 | 1 | 3 |
| Alagoas | 3 | 0.2 | 37.2 | 2 | 3 |
| Total | 226 | 16.8 | 40.7 | 27 | 76 |
| Southern | |||||
| Rio Grande do Sul | 132 | 9.8 | 57.5 | 12 | 37 |
| Paraná | 70 | 5.2 | 22.1 | 9 | 28 |
| Santa Catarina | 34 | 2.6 | 30.5 | 4 | 13 |
| Total | 236 | 17.6 | 37.4 | 25 | 78 |
| Northern | |||||
| Pará | 56 | 4.2 | 50.4 | 5 | 18 |
| Amazonas | 42 | 3.1 | 81.2 | 3 | 15 |
| Rondônia | 7 | 0.5 | 39.6 | 1 | 3 |
| Roraima | 2 | 0.1 | 31.8 | 1 | 1 |
| Acre | 1 | 0.1 | 51.1 | 1 | 1 |
| Amapá | 1 | 0.1 | 30.1 | 1 | 1 |
| Tocantins | 1 | 0.1 | 12.6 | 1 | 1 |
| Total | 110 | 8.2 | 51.6 | 13 | 40 |
| Midwest | |||||
| Distrito Federal | 30 | 2.3 | 15.2 | 3 | 10 |
| Goiás | 27 | 2.0 | 15.3 | 3 | 10 |
| Mato Grosso do Sul | 27 | 2.0 | 41.5 | 3 | 7 |
| Mato Grosso | 3 | 0.2 | 43.9 | 1 | 2 |
| Total | 87 | 6.5 | 25.9 | 10 | 29 |
| Brazil | 1,342 | 100.0 | 41.9 | 121 | 416 |